Enterohemorrhagic Escherichia coli (EHEC)

Scandinavian Journal of Infectious Diseases

Volumn 37, Issue 6-7, 2005, Pages 405-416

  Welinder Olsson, Christina ^a   Kaijser, Bertil ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; IRON; VEROTOXIN 1; VEROTOXIN 2;

BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CHILD CARE; DIARRHEA; DISEASE SEVERITY; ENTEROBACTER INFECTION; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ESCHERICHIA COLI; FIMBRIA; HEMOLYTIC UREMIC SYNDROME; HEMORRHAGIC COLITIS; NONHUMAN; PATHOGENICITY; PLASMID; POLYMERASE CHAIN REACTION; PROTEIN FUNCTION; REVIEW; SCREENING TEST; TOXIN SYNTHESIS;

ANIMALS; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; HUMANS; SHIGA TOXINS; SHIGA-LIKE TOXIN I; VIRULENCE;

EID: 22844449645     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540510038523     Document Type: Review

References (115)

1. Konowalchuk J, Speirs JI, Stavric S. Vero response to a cytotoxin of Escherichia coli. Infect Immun 1977;18:775-9.
2. O'Brien AD, LaVeck GD. Purification and characterization of a Shigella dysenteriae 1-like toxin produced by Escherichia coli. Infect Immun 1983;40:675-83.
3. Riley LW, Remis RS, Helgerson SD, McGee HB, Wells JG, Davis BR, et al. Haemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med 1983;308:681-5.
4. Fukushima H, Hashizume T, Morita Y, Tanaka J, Azuma K, Mizumoto Y, et al. Clinical experiences in Sakai City Hospital during the massive outbreak of enterohaemorrhagic Escherichia coli O157 infections in Sakai City, 1996. Pediatr Int 1999;41:213-7.
5. Carter AO, Borczyk AA, Carlson JA, Harvey B, Hockin JC, Karmali MA, et al. A severe outbreak of Escherichia coli O157:H7-associated haemorrhagic colitis in a nursing home. N Engl J Med 1987;317:1496-500.
6. Slutsker L, Ries AA, Greene KD, Wells JG, Hutwagner L, Griffin PM. Escherichia coli O157:H7 diarrhoea in the United States: clinical and epidemiological features. Ann Intern Med 1997;126:505-13.
7. Rowe PC, Orrbine E, Lior H, Wells GA, Yetisir E, Clulow M, McLaine PN. Risk of haemolytic uraemic syndrome after sporadic Escherichia coil O157:H7 infection: results of a Canadian collaborative study. Investigators of the Canadian Pediatric Kidney Disease Research Center. J Pediatr 1998;132:777-82.
8. Griffin PM, Tauxe RV. The epidemiotogy of infections caused by Escherichia coli O157:H7, other enterohaemorrhagic E. coli, and the associated haemolytic uraemic syndrome. Epidemiol Rev 1991;13:60-98.
9. Karmali MA. Infection by verocytotoxin-producing Escherichia coli. Clin Microbiol Rev 1989;2:15-38.
10. Tarr PI. Escherichia coli O157:H7: clinical, diagnostic, and epidemiological aspects of human infection. Clin Infect Dis 1995;20:1-8; quiz 9-10.
11. Paton JC, Paton AW. Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin Microbiol Rev 1998;11:450-79.
12. Nataro JP, Kaper JB. Diarrhoeagenic Escherichia coli. Clin Microbiol Rev 1998;11:142-201.
13. Welinder-Olsson C, Stenqvist K, Badenfors M, Brandberg A, Floren K, Holm M, et al. EHEC outbreak among staff at a children's hospital: use of PCR for verocytotoxin detection and PFGE for epidemiological investigation. Epidemiol Infect 2004;132:43-9.
14. Dean-Nystrom EA, Gansheroff LJ, Mills M, Moon HW, O'Brien AD. Vaccination of pregnant dams with intimin (O157) protects suckling piglets from Escherichia coli O157:H7 infection. Infect Immun 2002;70:2414-8.
15. Wieler LH, Vieler E, Erpenstein C, Schlapp T, Steinruck H, Bauerfeind R, et al. Shiga toxin-producing Escherichia coli strains from bovines: association of adhesion with carriage of eae and other genes. J Clin Microbiol 1996;34: 2980-4.
16. Jerse AE, Yu J, Tall BD, Kaper JB. A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. Proc Natl Acad Sci USA 1990;87:7839-43.
17. Yu J, Kaper JB. Cloning and characterization of the eae gene of enterohaemorrhagic Escherichia coli O157:H7. Mol Microbiol 1992;6:411-7.
18. Donnenberg MS, Tzipori S, McKee ML, O'Brien AD, Alroy J, Kaper JB. The role of the eae gene of enterohaemorrhagic Escherichia coli in intimate attachment in vitro and in a porcine model. J Clin Invest 1993;92:1418-24.
19. Rosenshine I, Ruschkowski S, Stein M, Reinscheid DJ, Mills SD, Finlay BB. A pathogenic bacterium triggers epithelial signals to form a functional bacterial receptor that mediates actin pseudopod formation. Embo J 1996; 15: 2613-24.
20. Kenny B, DeVinney R, Stein M, Reinscheid DJ, Frey EA, Finlay BB. Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 1997;91:511-20.
21. DeVinney R, Stein M, Reinscheid D, Abe A, Ruschkowski S, Finlay BB. Enterohaemorrhagic Escherichia coli O157:H7 produces Tir, which is translocated to the host cell membrane but is not tyrosine phosphorylated. Infect Immun 1999;67:2389-98.
22. Louie M, de Azavedo J, Clarke R, Borczyk A, Lior H, Richter M, Brunton J. Sequence heterogeneity of the eae gene and detection of verotoxin-producing Escherichia coli using serotype-specific primers. Epidemiol Infect 1994;112: 449-61.
23. Beutin L, Geier D, Steinruck H, Zimmermann S, Scheutz F. Prevalence and some properties of verotoxin (Shiga-like toxin)-producing Escherichia coli in 7 different species of healthy domestic animals. J Clin Microbiol 1993;31:2483-8.
24. Duguid JP, Smith IW, Dempster G, Edmunds PN. Non-flagellar filamentous appendages (fimbriae) and haemagglutinating activity in Bacterium coli. J Pathol Bacteriol 1955;70:335-48.
25. Johnson JR. Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 1991;4:80-128.
26. Friman V, Nowrouzian F, Adlerberth I, Wold AE. Increased frequency of intestinal Escherichia coli carrying genes for S fimbriae and haemolysin in IgA-deficient individuals. Microb Pathog 2002;32:35-42.
27. Abraham SN, Goguen JD, Beachey EH. Hyperadhesive mutant of type 1-fimbriated Escherichia coli associated with formation of FimH organelles (fimbriosomes). Infect Immun 1988;56:1023-9.
28. Abraham SN, Goguen JD, Sun D, Klemm P, Beachey EH. Identification of 2 ancillary subunits of Escherichia coli type 1 fimbriae by using antibodies against synthetic oligopeptides of fim gene products. J Bacteriol 1987;169:5530-6.
29. Enami M, Nakasone N, Honma Y, Kakinohana S, Kudaka J, Iwanaga M. Expression of type 1 pili is abolished in verotoxin-producing Escherichia coli O157. FEMS Microbiol Lett 1999;179:467-72.
30. Roe AJ, Currie C, Smith DG, Gally DL. Analysis of type 1 fimbriae expression in verotoxigenic Escherichia coli: a comparison between serotypes O157 and 026. Microbiology 2001;147:145-52.
31. Welinder-Olsson C, Eriksson E, Kaijser B. Virulence genes in verocytotoxigenic Escherichia coli strains isolated from humans and cattle. APMIS 2005.
32. Mack DR, Michail S, Wei S, McDougall L, Hollingsworth MA. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol 1999;276:G941-50.
33. Leffler H, Svanborg Edén C. Chemical identification of a glycosphingolipid receptor for Escherichia coli attaching to human urinary tract epithelial cells and agglutinating human erythrocytes. FEMS Microbiol Letters 1980;8: 127-34.
34. Leffler H, Svanborg-Eden C. Glycolipid receptors for uropathogenic Escherichia coli on human erythrocytes and uroepithelial cells. Infect Immun 1981;34:920-9.
35. Parkkinen J, Ristimaki A, Westerlund B. Binding of Escherichia coli S fimbriae to cultured human endothelial cells. Infect Immun 1989;57:2256-9.
36. Korhonen TK, Virkola R, Westurlund B, Holthofer H, Parkkinen J. Tissue tropism of Escherichia coli adhesins in human extraintestinal infections. Curr Top Microbiol Immunol 1990;151:115-27.
37. Prasadarao NV, Wass CA, Hacker J, Jann K, Kim KS. Adhesion of S-fimbriated Escherichia coli to brain glycolipids mediated by sfaA gene-encoded protein of S fimbriae. J Biol Chem 1993;268:10356-63.
38. Nowicki B, Labigne A, Moseley S, Hull R, Hull S, Moulds J. The Dr haemagglutinin, afimbrial adhesins AFA-I and AFA-III, and F fimbriae of uropathogenic and diarrhoea-associated Escherichia coli belong to a family of haemagglutinins with Dr receptor recognition. Infect Immun ;58 1845;1990:279-81.
39. Nowicki B, Hart A, Coyne KE, Lublin DM, Nowicki S. Short consensus repeat-3 domain of recombinant decay-accelerating factor is recognized by Escherichia coli recombinant Dr adhesin in a model of a cell-cell interaction. J Exp Med 1993;178:2115-21.
40. Bilge SS, Clausen CR, Lau W, Moseley SL. Molecular characterization of a fimbrial adhesin, F, mediating diffuse adherence of diarrhoea-associated Escherichia coli to HEp-2 cells. J Bacteriol ;171 1845;1989:4281-9.
41. Weinberg ED. Iron and infection. Microbiol Rev 1978;42: 45-66.
42. Neilands JB, Bindereif A, Montgomerie JZ. Genetic basis of iron assimilation in pathogenic Escherichia coli. Curr Top Microbiol Immunol 1985;118:179-95.
43. de Lorenzo V, Neilands JB. Characterization of iucA and iucC genes of the aerobactin system of plasmid ColV-K30 in Escherichia coli. J Bacteriol 1986;167:350-5.
44. Montgomerie JZ, Bindereif A, Neilands JB, Kalmanson GM, Guze LB. Association of hydroxamate siderophore (aerobactin) with Escherichia coli isolated from patients with bacteraemia. Infect Immun 1984;46:835-8.
45. de Lorenzo V, Bindereif A, Paw BH, Neilands JB. Aerobactin biosynthesis and transport genes of plasmid ColV-K30 in Escherichia coli K-12. J Bacteriol 1986;165:570-8.
46. Valvano MA, Silver RP, Crosa JH. Occurrence of chromosome-or plasmid-mediated aerobactin iron transport systems and haemolysin production among clonal groups of human invasive strains of Escherichia coli K1. Infect Immun 1986;52:192-9.
47. Johnson JR, Moseley SL, Roberts PL, Stamm WE. Aerobactin and other virulence factor genes among strains of Escherichia coli causing urosepsis: association with patient characteristics. Infect Immun 1988;56:405-12.
48. Cavalieri SJ, Bohach GA, Snyder IS. Escherichia coli alphahaemolysin: characteristics and probable role in pathogenicity. Microbiol Rev 1984;48:326-43.
49. Welch RA, Falkow S. Characterization of Escherichia coli haemolysins conferring quantitative differences in virulence. Infect Immun 1984;43:156-60.
50. Nicaud JM, Mackman N, Gray L, Holland IB. Characterization of HlyC and mechanism of activation and secretion of haemolysin from E. coli 2001. FEBS Lett 1985;187: 339-44.
51. Wagner W, Kuhn M, Goebel W. Active and inactive forms of haemolysin (HlyA) from Escherichia coli Biol Chem Hoppe Seyler 1988;369:39-46.
52. Law D, Kelly J. Use of haem and haemoglobin by Escherichia coli O157 and other Shiga-like-toxin-producing E. coli serogroups. Infect Immun 1995;63:700-2.
53. Paros M, Tarr PI, Kim H, Besser TE, Hancock DD. A comparison of human and bovine Escherichia coli O157:H7 isolates by toxin genotype, plasmid profile, and bacteriophage lambda-restriction fragment length polymorphism profile. J Infect Dis 1993;168:1300-3.
54. Ostroff SM, Tarr PI, Neill MA, Lewis JH, Hargrett-Bean N, Kobayashi JM. Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections. J Infect Dis 1989;160:994-8.
55. Wells JG, Davis BR, Wachsmuth IK, Riley LW, Remis RS, Sokolow R, Morris GK. Laboratory investigation of haemorrhagic colitis outbreaks associated with a rare Escherichia coli serotype. J Clin Microbiol 1983;18:512-20.
56. Schmidt H, Kernbach C, Karch H. Analysis of the EHEC hly operon and its location in the physical map of the large plasmid of enterohaemorrhagic Escherichia coli O157:h7. Microbiology 1996;142:907-14.
57. Bauer ME, Welch RA. Characterization of an RTX toxin from enterohaemorrhagic Escherichia coli O157:H7. Infect Immun 1996;64:167-75.
58. Schmidt H, Beutin L, Karch H. Molecular analysis of the plasmid-encoded haemolysin of Escherichia coli O157:H7 strain EDL 933. Infect Immun 1995;63:1055-61.
59. Torres AG, Payne SM. Haem iron-transport system in enterohaemorrhagic Escherichia coli O157:H7. Mol Microbiol 1997;23:825-33.
60. Brunder W, Schmidt H, Karch H. KatP, a novel catalaseperoxidase encoded by the large plasmid of enterohaemorrhagic Escherichia coli O157:H7. Microbiology 1996;142: 3305-15.
61. Farr SB, Kogoma T. Oxidative stress responses in Escherichia coli and Salmonella typhimurium. Microbiol Rev 1991;55:561-85.
62. Loewen PC, Triggs BL, George CS, Hrabarchuk BE. Genetic mapping of katG, a locus that affects synthesis of the bifunctional catalase-peroxidase hydroperoxidase I in Escherichia coli. J Bacteriol 1985;162:661-7.
63. Schmidt H, Henkel B, Karch H. A gene cluster closely related to type II secretion pathway operons of Gram-negative bacteria is located on the large plasmid of enterohaemorrhagic Escherichia coli O157 strains. FEMS Microbiol Lett 1997;148:265-72.
64. Brunder W, Schmidt H, Karch H. EspP, a novel extracellular serine protease of enterohaemorrhagic Escherichia coli O157:H7 cleaves human coagulation factor V. Mol Microbiol 1997;24:767-78.
65. Welinder-Olsson C, Badenfors M, Cheasty T, Kjellin E, Kaijser B. Genetic profiling of enterohemorrhagic Escherichia coli strains in relation to clonality and clinical signs of infection. J Clin Microbiol 2002;40:959-64.
66. O'Brien AD, Tesh VL, Donohue-Rolfe A, Jackson MP, Olsnes S, Sandvig K, et al. Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis. Curr Top Microbiol Immunol 1992;180:65-94.
67. Schmidt H. Shiga-toxin-converting bacteriophages. Res Microbiol 2001;152:687-95.
68. Fraser ME, Chernaia MM, Kozlov YV, James MN. Crystal structure of the holotoxin from Shigella dysenteriae at 2.5 A resolution. Nat Struct Biol 1994;1:59-64.
69. Lingwood CA. Role of verotoxin receptors in pathogenesis. Trends Microbiol 1996;4:147-53.
70. Hurley BP, Jacewicz M, Thorpe CM, Lincicome LL, King AJ, Keusch GT, Acheson DW. Shiga toxins 1 and 2 translocate differently across polarized intestinal epithelial cells. Infect Immun 1999;67:6670-7.
71. Thorpe CM, Hurley BP, Lincicome LL, Jacewicz MS, Keusch GT, Acheson DW. Shiga toxins stimulate secretion of interleukin-8 from intestinal epithelial cells. Infect Immun 1999;67:5985-93.
72. Te Loo DM, Monnens LA, van Der Velden TJ, Vermeer MA, Preyers F, Demacker PN, et al. Binding and transfer of verocytotoxin by polymorphonuclear leukocytes in haemolytic uraemic syndrome. Blood 2000;95:3396-402.
73. Te Loo DM, van Hinsbergh VW, van den Heuvel LP, Monnens LA. Detection of verocytotoxin bound to circulating polymorphonuclear leukocytes of patients with haemolytic uraemic syndrome. J Am Soc Nephrol 2001;12: 800-6.
74. Cherla RP, Lee SY, Tesh VL. Shiga toxins and apoptosis. FEMS Microbiol Lett 2003;228:159-66.
75. Moxley. Overview of animal models, in Escherichia coli O157:H7 and other Shiga toxin-producing E. coli strains, K.J.B.a. O'Brien, Editor. 1998, ASM Press: Washington DC. pp 249-60.
76. Richardson SE, Karmali MA, Becker LE, Smith CR. The histopathology of the haemolytic uraemic syndrome associated with verocytotoxin-producing Escherichia coli infections. Hum Pathol 1988;19:1102-8.
77. Nielsen EM, Scheutz F. Characterization of Escherichia coli O157 isolates from Danish cattle and human patients by genotyping and presence and variants of virulence genes. Vet Microbiol 2002;88:259-73.
78. Dorn CR, Francis DH, Angrick EJ, Willgohs JA, Wilson RA, Collins JE, et al. Characteristics of verocytotoxin producing Escherichia coli associated with intestinal colonization and diarrhoea in calves. Vet Microbiol 1993;36: 149-59.
79. Leclercq A, Mahillon J. Farmed rabbits and ducks as vectors for VTEC O157:H7. Vet Rec 2003;152:723-4.
80. Karch H, Russmann H, Schmidt H, Schwarzkopf A, Heesemann J. Long-term shedding and clonal turnover of enterohaemorrhagic Escherichia coli O157 in diarrhoeal diseases. J Clin Microbiol 1995;33:1602-5.
81. Welinder-Olsson C, Kjellin E, Badenfors M, Kaijser B. Improved microbiological techniques using the polymerase chain reaction and pulsed-field gel electrophoresis for diagnosis and follow-up of enterohaemorrhagic Escherichia coli infection. Eur J Clin Microbiol Infect Dis 2000;19: 843-51.
82. CDC. Foodborne outbreak of gastroenteritis caused by Escherichia coli O157:H7, North Dakota, 1990. MMWR Morb Mortal Wkly Rep Centers for Disease Control. 1991;40:265-7.
83. Su C, Brandt LJ. Escherichia coli O157:H7 infection in humans. Ann Intern Med 1995;123:698-714.
84. Ryan CA, Tauxe RV, Hosek GW, Wells JG, Stoesz PA, McFadden HW Jr, et al. Escherichia coli O157:H7 diarrhoea in a nursing home: clinical, epidemiological, and pathological findings. J Infect Dis 1986;154:631-8.
85. Cobbold R, Desmarchelier P. A longitudinal study of Shigatoxigenic Escherichia coli (STEC) prevalence in 3 Australian diary herds. Vet Microbiol 2000;71:125-37.
86. Blanco M, Blanco JE, Blanco J, Gonzalez EA, Mora A, Prado C, et al. Prevalence and characteristics of Escherichia coli serotype O157:H7 and other verotoxin-producing E. coli in healthy cattle. Epidemiol Infect 1996;117:251-7.
87. Wells JG, Shipman LD, Greene KD, Sowers EG, Green JH, Cameron DN, et al. Isolation of Escherichia coli serotype O157:H7 and other Shiga-like toxin-producing E. coli from dairy cattle. J Clin Microbiol 1991;29: 985-9.
88. Gansheroff LJ, O'Brien AD. Escherichia coli O157:H7 in beef cattle presented for slaughter in the US: higher prevalence rates than previously estimated. Proc Natl Acad Sci USA 2000;97:2959-61.
89. Jenkins C, Pearce MC, Chart H, Cheasty T, Willshaw GA, Gunn GJ, et al. An 8-month study of a population of verocytotoxigenic Escherichia coli (VTEC) in a Scottish cattle herd. J Appl Microbiol 2002;93:944-53.
90. Galfi P, Neogrady S, Semjen G, Bardocz S, Pusztai A. Attachment of different Escherichia coli strains to cultured rumen epithelial cells. Vet Microbiol 1998;61:191-7.
91. Bertin Y, Martin C, Girardeau IP, Pohl P, Contrepois M. Association of genes encoding P fimbriae, CS31A antigen and EAST 1 toxin among CNF1-producing Escherichia coli strains from cattle with septicaemia and diarrhoea. FEMS Microbiol Lett 1998;162:235-9.
92. Mainil JG, Jacquemin ER, Kaeckenbeeck AE, Pohl PH. Association between the effacing (eae) gene and the Shiga-like toxin-encoding genes in Escherichia coli isolates from cattle. Am J Vet Res 1993;54:1064-8.
93. Karch H, Heesemann J, Lanfs R, O'Brien AD, Tacket CO, Levine MM. A plasmid of enterohaemorrhagic Escherichia coli O157:H7 is required for expression of a new fimbrial antigen and for adhesion to epithelial cells. Infect Immun 1987;55:455-61.
94. Toth I, Cohen ML, Rumschlag HS, Riley LW, White EH, Carr JH, et al. Influence of the 60-megadalton plasmid on adherence of Escherichia coli O157:H7 and genetic derivatives. Infect Immun 1990;58:1223-31.
95. Schmidt H, Zhang WL, Hemmrich U, Jelacic S, Brunder W, Tart PI, et ah Identification and characterization of a novel genomic island integrated at selC in locus of enterocyte effacement-negative, Shiga toxin-producing Escherichia coll. Infect Immun 2001;69:6863-73.
96. Brunder W, Khan AS, Hacker J, Karch H. Novel type of fimbriae encoded by the large plasmid of sorbitol-fermenting enterohaemorrhagic Escherichia coli O157:H(-). Infect Immun 2001;69:4447-57.
97. Doughty S, Sloan J, Bennett-Wood V, Robertson M, Robins-Browne RM, Hartland EL. Identification of a novel fimbrial gene cluster related to long polar fimbriae in locus of enterocyte effacement-negative strains of enterohaemorrhagic Escherichia coli. Infect Immun 2002;70: 6761-9.
98. Sandhu KS, Clarke RC, Gyles CL. Haemolysin phenotypes and genotypes of eaeA-positive and eaeA-negative bovine verotoxigenic Escherichia coli. Adv Exp Med Biol 1997; 412:295-302.
99. Fecteau G, Fairbrother JM, Higgins R, Van Metre DC, Pare J, Smith BP, et al. Virulence factors in Escherichia coli isolated from the blood of bacteraemic neonatal calves. Vet Microbiol 2001;78:241-9.
100. Pulz M, Matussek A, Monazahian M, Tittel A, Nikolic E, Hartmann M, et al. Comparison of a Shiga toxin enzyme-linked immunosorbent assay and 2 types of PCR for detection of Shiga toxin-producing Escherichia coli in human stool specimens. J Clin Microbiol 2003;41:4671-5.
101. Begum D, Jackson MP. Direct detection of Shiga-like toxin-producing Escherichia coli in ground beef using the polymerase chain reaction. Mol Cell Probes 1995;9:259-64.
102. World Health Organization Scientific Working Group. Zoonotic non-O157 Shiga toxin-producing Escherichia coli (STEC). 1998 June 23-26. Berlin: World Health Organization, Geneva, Switzerland.
103. Bellin T, Pulz M, Matussek A, Hempen HG, Gunzer F. Rapid detection of enterohaemorrhagic Escherichia coli by real-time PCR with fluorescent hybridization probes. J Clin Microbiol 2001;39:370-4.
104. Rietman H, Birren B, Gnirke A. Preparation, Manipulation, and mapping of HMW DNA, in Genome analysis. A Laboratory Manual. Birren B, Green ED, Klapholz S, Myers RM, Roskams J, Editors. 1997. CSHL Press. pp 83-248.
105. Rowe P. Eradicating E. coli O157:H7. Lancet 1995;345: 117.
106. Grif K, Karch H, Schneider C, Daschner FD, Beutin L, Cheasty T, et al. Comparative study of 5 different techniques for epidemiological typing of Escherichia coli O157. Diagn Microbiol Infect Dis 1998;32:165-76.
107. Bender JB, Hedberg CW, Besser JM, Boxrud DJ, MacDonald KL, Osterholm MT. Surveillance by molecular subtype for Escherichia coli O157:H7 infections in Minnesota by molecular subtyping. N Engl J Med 1997;337:388-94.
108. Lindstedt BA, Heir E, Gjernes E, Vardund T, Kapperud G. DNA fingerprinting of Shiga-toxin producing Escherichia coli O157 based on multiple-locus variable-number tandem-repeats analysis (MLVA). Ann Clin Microbiol Antimicrob 2003;2:12.
109. Klevytska AM, Price LB, Schupp JM, Worsham PL, Wong J, Keim P. Identification and characterization of variable-number tandem repeats in the Yersinia pestis genome. J Clin Microbiol 2001;39:3179-85.
110. Le Fleche P, Fabre M, Denoeud F, Koeck JL, Vergnaud G. High resolution, on-line identification of strains from the Mycobacterium tuberculosis complex based on tandem repeat typing. BMC Microbiol 2002;2:37.
111. Parkkinen J, Finne J, Achtman M, Vaisanen V, Korhonen TK. Escherichia cob strains binding neuraminyl alpha 2-3 galactosides. Biochem Biophys Res Commun 1983;111: 456-61.
112. Ott M, Hacker J, Schmoll T, Jarchau T, Korhonen TK, Goebel W. Analysis of the genetic determinants coding for the S fimbrial adhesin (sfa) in different Escherichia coli strains causing meningitis or urinary tract infections. Infect Immun 1986;54:646-53.
113. Rennie RP, Arbuthnott JP. Partial characterisation of Escherichia coli haemolysin. J Med Microbiol 1974;7: 179-88.
114. Seeger W, Walter H, Suttorp N, Muhly M, Bhakdi S. Thromboxane-mediated hypertension and vascular leakage evoked by low doses of Escherichia coli haemolysin in rabbit lungs. J Clin Invest 1989;84:220-7.
115. Surtorp N, Floer B, Schnittler H, Seeger W, Bhakdi S. Effects of Escherichia coli haemolysin on endothelial cell function. Infect Immun 1990;58:3796-801.